Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, today announced the closing of a $600 million senior unsecured note offering by Oxford and Oxford Finance Co-Issuer II Inc., a wholly owned subsidiary of Oxford. The notes bear interest at a fixed rate of 7.750% and mature in 2031. Oxford intends to use the net proceeds of this offering to redeem its $400 million 6.375% Senior Notes due 2027 and repay a portion of its funding debt.
The notes were offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), that are qualified purchasers, as defined in Section 2(a)(51) of the Investment Company Act of 1940, as amended. The notes have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States or to U.S. persons absent registration or an applicable exemption from the registration requirements.
This press release does not constitute an offer to sell the notes, nor a solicitation for an offer to purchase the notes. The offering was made only by means of a confidential offering memorandum.
About Oxford Finance LLC
Oxford Finance LLC is a specialty finance firm providing senior secured loans to public and private companies operating in a variety of industries worldwide. For over 20 years, Oxford has delivered flexible financing solutions to over 750 companies, allowing borrowers to maximize their equity by leveraging their assets. Since 2002, Oxford has originated more than $18 billion in loans. Oxford is headquartered in Alexandria, Virginia, with additional offices serving the greater San Diego, San Francisco, Atlanta and New York City metropolitan areas. For more information, visit https://oxfordfinance.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260511118902/en/
Media gallery
